Valneva Vaccinates First Participant in Pediatric Trial of Single-Shot Chikungunya Vaccine
Saint-Herblain , January 10, 2024 – Valneva SE today announced that the first participant has been vaccinated in the Phase 2 clinical trial evaluating the safety and Immunogenicity in children of...